Literature DB >> 2295248

Severe bradycardia following electrical cardioversion for atrial tachyarrhythmias in patients with acute myocardial infarction.

P M Mehta1, B R Reddy, J Lesser, P E Carson.   

Abstract

Bradycardia following electrical cardioversion is an uncommon complication. The present report describes three patients who developed life-threatening bradycardia following electrical cardioversion for atrial tachyarrhythmias in the setting of an acute myocardial infarction. All three patients had multivessel coronary artery disease with a totally occluded right coronary artery and a possibility of ischemic sinus node dysfunction. When electrical cardioversion is undertaken for new onset of atrial tachyarrhythmia in the setting of an acute myocardial infarction, measures for immediate, temporary pacing should be easily available.

Entities:  

Mesh:

Year:  1990        PMID: 2295248     DOI: 10.1378/chest.97.1.241

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  5 in total

1.  Synchronised cardioversion for chronic atrail fibrillation.

Authors:  E Aniteye; D Kotei; M Tettey; L Sereboe; F Edwin; A Doku; M Tamatey; K Entsuah-Mensah; S Batista; K Frimpong-Boateng
Journal:  Ghana Med J       Date:  2008-03

2.  Cardioversion: past, present, and future.

Authors:  Ivan Cakulev; Igor R Efimov; Albert L Waldo
Journal:  Circulation       Date:  2009-10-20       Impact factor: 29.690

Review 3.  Cardioversion of atrial fibrillation.

Authors:  G Y Lip
Journal:  Postgrad Med J       Date:  1995-08       Impact factor: 2.401

Review 4.  Electric cardioversion of atrial fibrillation.

Authors:  Maen Nusair; Greg C Flaker; Anand Chockalingam
Journal:  Mo Med       Date:  2010 Jan-Feb

5.  The Impact of Personal Thoracic Impedance on Electrical Cardioversion in Patients with Atrial Arrhythmias.

Authors:  Seung-Young Roh; Jinhee Ahn; Kwang-No Lee; Yong-Soo Baek; Dong-Hyeok Kim; Dae-In Lee; Jaemin Shim; Jong-Il Choi; Young-Hoon Kim
Journal:  Medicina (Kaunas)       Date:  2021-06-13       Impact factor: 2.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.